Publicacións nas que colabora con FELIPE CASANUEVA FREIJO (45)

2022

  1. Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21

    Nature Metabolism, Vol. 4, Núm. 7, pp. 901-917

2020

  1. Analysis of platelets from a diet-induced obesity rat model: elucidating platelet dysfunction in obesity

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. A Combination of Proteomic Approaches Identifies A Panel of Circulating Extracellular Vesicle Proteins Related to the Risk of Suffering Cardiovascular Disease in Obese Patients

    Proteomics, Vol. 19, Núm. 1-2

  2. Data on hyper-activation of GPVI signalling in obese patients: Towards the identification of novel antiplatelet targets in obesity

    Data in Brief

  3. GPVI surface expression and signalling pathway activation are increased in platelets from obese patients: Elucidating potential anti-atherothrombotic targets in obesity

    Atherosclerosis, Vol. 281, pp. 62-70

2017

  1. Evolution and bad prognostic value of advanced glycation end products after acute heart failure: Relation with body composition

    Cardiovascular Diabetology, Vol. 16, Núm. 1

  2. Non classical Monocytes Levels, Increased by Subcutaneous Fat-Secretome, Are Associated with Less Rehospitalization after Heart Failure Admission

    Journal of Cardiovascular Translational Research, Vol. 10, Núm. 1, pp. 16-26

  3. Orosomucoid as prognosis factor associated with inflammation in acute or nutritional status in chronic heart failure

    International Journal of Cardiology, Vol. 228, pp. 488-494

  4. Pharmacological inhibition of cannabinoid receptor 1 stimulates gastric release of nesfatin-1 via the mTOR pathway

    World Journal of Gastroenterology, Vol. 23, Núm. 35, pp. 6403-6411

2016

  1. Distinct phosphorylation sites on the ghrelin receptor, GHSR1a, establish a code that determines the functions of ß-arrestins

    Scientific Reports, Vol. 6

  2. Impact of mean cell hemoglobin on Hb A1c-defined glycemia status

    Clinical Chemistry, Vol. 62, Núm. 12, pp. 1570-1578

  3. Uroguanylin action in the brain reduces weight gain in obese mice via different efferent autonomic pathways

    Diabetes, Vol. 65, Núm. 2, pp. 421-432

  4. Uroguanylin levels in intestine and plasma are regulated by nutritional status in a leptin-dependent manner

    European Journal of Nutrition, Vol. 55, Núm. 2, pp. 529-536

2015

  1. Ghrelin

    Molecular Metabolism, Vol. 4, Núm. 6, pp. 437-460

  2. Influence of the glycation gap on the diagnosis of type 2 diabetes

    Acta Diabetologica, Vol. 52, Núm. 3, pp. 453-459

  3. Regulation of NUCB2/nesfatin-1 production in rat's stomach and adipose tissue is dependent on age, testosterone levels and lactating status

    Molecular and Cellular Endocrinology, Vol. 411, pp. 105-112

2013

  1. Interleukin 6 Deficiency Modulates the Hypothalamic Expression of Energy Balance Regulating Peptides during Pregnancy in Mice

    PLoS ONE, Vol. 8, Núm. 8

2012

  1. Estimation of the glycation gap in diabetic patients with stable glycemic control

    Diabetes Care, Vol. 35, Núm. 12, pp. 2447-2450

  2. Intrapersonal HbA1c variability and the risk of progression of nephropathy in patients with Type2 diabetes

    Diabetic Medicine, Vol. 29, Núm. 12, pp. 1562-1566

2011

  1. Oleoylethanolamide: Effects on hypothalamic transmitters and gut peptides regulating food intake

    Neuropharmacology, Vol. 60, Núm. 4, pp. 593-601